Loss widens at Dyax
February 21, 2007 08:20 AM
E-mail|
|Comments
()|
Text size
–
+
Dyax Corp.'s fourth-quarter loss widened to $20.2 million, or 46 cents a share.
That compares to $5.61 million, or 15 cents a share, a year earlier.
The Cambridge pharmaceutical company said revenue fell 57% to $3.16 million from $7.3 million due in part to the completion of a product collaboration. The company said the year-ago period included a milestone payment.
Research and development costs rose to $20.1 million from $11.3 million. (AP)
Comment
Permalink
E-mail
